XRAY logo

DENTSPLY SIRONA Inc. (XRAY)

$9.44

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on XRAY

Market cap

$1.88B

EPS

-2.75

P/E ratio

--

Price to sales

0.48

Dividend yield

6.78%

Beta

0.872151

Price on XRAY

Previous close

$9.35

Today's open

$9.34

Day's range

$9.20 - $9.48

52 week range

$8.32 - $14.76

Profile about XRAY

CEO

Simon D. Campion

Employees

14000

Headquarters

Charlotte, NC

Exchange

Nasdaq Global Select

Shares outstanding

199353876

Issue type

Common Stock

XRAY industries and sectors

Healthcare

Medical Equipment & Supplies

News on XRAY

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

news source

PRNewsWire • Oct 27, 2026

news preview

Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5

CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, November 5, 2026, at 4:30 p.m. EST to review its third quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.

news source

GlobeNewsWire • Oct 20, 2026

news preview

Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal

XRAY expands its U.S. distribution reach through Midwest Dental, aiming to boost digital dentistry adoption and broaden access to its technology portfolio.

news source

Zacks Investment Research • Oct 12, 2026

news preview

Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity™ portfolio, including the Surity™ Urinary Management System and Surity™ Female and Male External Catheters, may be covered by traditional Medicare for eligible beneficiaries when medically necessary. This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S.

news source

GlobeNewsWire • Oct 7, 2026

news preview

Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement

The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and technology. The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and technology.

news source

GlobeNewsWire • Oct 6, 2026

news preview

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now

XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.

news source

Zacks Investment Research • Sep 17, 2026

news preview

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure

XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.

news source

Zacks Investment Research • Sep 8, 2026

news preview

Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference

CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global Healthcare Conference. Management is scheduled to present on Tuesday, September 15, 2026, at 11:25 a.m. ET.

news source

GlobeNewsWire • Sep 3, 2026

news preview

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

"I'll give you 950 billion reasons to buy bonds right now," says Thomas Hayes, who gives a contrarian take on why investors should bolster their portfolios in fixed income. He discusses the "seasonality effect," a crowded AI trade, a complicated geopolitical picture, and a steady rise in crude oil as components he sees leading a lasting bond rally.

news preview

New At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary Incontinence

New system completes the Surity™  portfolio of external catheters for both men and women Integrates into daily routines to help support management of urinary incontinence at home Designed to operate quietly overnight, new Surity™ System helps minimize nighttime interruptions to support comfort and rest MÖLNDAL, Sweden, Aug. 19, 2026 /PRNewswire/ -- Wellspect HealthCare today announced the U.S. launch of the Surity™ Urinary Management System, a discreet at-home urine collection device designed to support people living with urinary incontinence and those who help care for them. This completes the full Surity™ portfolio in the U.S., following the introduction of the Surity™ Female and Male External Catheters earlier this year.

news source

PRNewsWire • Aug 19, 2026

news preview

¹ Disclosures

Get started with M1

Invest in DENTSPLY SIRONA Inc.

Open an M1 investment account to buy and sell DENTSPLY SIRONA Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in XRAY on M1